Fluorine in PDB 7l01: Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide)
Enzymatic activity of Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide)
All present enzymatic activity of Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide):
1.3.5.2;
Protein crystallography data
The structure of Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide), PDB code: 7l01
was solved by
X.Deng,
M.Phillips,
D.Tomchick,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
33.39 /
1.60
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
50.059,
158.027,
61.05,
90,
104.6,
90
|
R / Rfree (%)
|
16.4 /
18.8
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide)
(pdb code 7l01). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide), PDB code: 7l01:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 7l01
Go back to
Fluorine Binding Sites List in 7l01
Fluorine binding site 1 out
of 6 in the Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1001
b:24.6
occ:1.00
|
F27
|
A:XCV1001
|
0.0
|
24.6
|
1.0
|
C26
|
A:XCV1001
|
1.4
|
21.2
|
1.0
|
F29
|
A:XCV1001
|
2.2
|
23.4
|
1.0
|
F28
|
A:XCV1001
|
2.2
|
25.5
|
1.0
|
H241
|
A:XCV1001
|
2.4
|
21.5
|
1.0
|
C25
|
A:XCV1001
|
2.4
|
15.2
|
1.0
|
C24
|
A:XCV1001
|
2.7
|
17.9
|
1.0
|
HD13
|
A:LEU187
|
2.7
|
28.0
|
1.0
|
HB3
|
A:LEU187
|
3.3
|
22.3
|
1.0
|
HD12
|
A:LEU187
|
3.4
|
28.0
|
1.0
|
CD1
|
A:LEU187
|
3.5
|
23.3
|
1.0
|
N30
|
A:XCV1001
|
3.6
|
19.2
|
1.0
|
HB2
|
A:LEU187
|
3.7
|
22.3
|
1.0
|
HD11
|
A:LEU191
|
3.9
|
29.9
|
1.0
|
CB
|
A:LEU187
|
3.9
|
18.5
|
1.0
|
SG
|
A:CYS175
|
3.9
|
30.5
|
1.0
|
C23
|
A:XCV1001
|
4.1
|
16.2
|
1.0
|
HD11
|
A:LEU187
|
4.2
|
28.0
|
1.0
|
HG
|
A:CYS175
|
4.3
|
36.6
|
1.0
|
CG
|
A:LEU187
|
4.3
|
24.5
|
1.0
|
HD12
|
A:LEU191
|
4.5
|
29.9
|
1.0
|
HD22
|
A:LEU187
|
4.6
|
33.5
|
1.0
|
CD1
|
A:LEU191
|
4.6
|
24.8
|
1.0
|
H231
|
A:XCV1001
|
4.6
|
19.5
|
1.0
|
HB3
|
A:PHE171
|
4.6
|
33.5
|
1.0
|
C31
|
A:XCV1001
|
4.7
|
16.5
|
1.0
|
C22
|
A:XCV1001
|
4.9
|
17.1
|
1.0
|
HA
|
A:CYS184
|
4.9
|
19.9
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 7l01
Go back to
Fluorine Binding Sites List in 7l01
Fluorine binding site 2 out
of 6 in the Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1001
b:25.5
occ:1.00
|
F28
|
A:XCV1001
|
0.0
|
25.5
|
1.0
|
C26
|
A:XCV1001
|
1.4
|
21.2
|
1.0
|
F29
|
A:XCV1001
|
2.2
|
23.4
|
1.0
|
F27
|
A:XCV1001
|
2.2
|
24.6
|
1.0
|
C25
|
A:XCV1001
|
2.4
|
15.2
|
1.0
|
HD11
|
A:LEU191
|
2.8
|
29.9
|
1.0
|
N30
|
A:XCV1001
|
2.9
|
19.2
|
1.0
|
C24
|
A:XCV1001
|
3.4
|
17.9
|
1.0
|
CD1
|
A:LEU191
|
3.5
|
24.8
|
1.0
|
HD12
|
A:LEU191
|
3.6
|
29.9
|
1.0
|
HD13
|
A:LEU191
|
3.6
|
29.9
|
1.0
|
H241
|
A:XCV1001
|
3.6
|
21.5
|
1.0
|
HD2
|
A:PHE171
|
4.1
|
49.1
|
1.0
|
O
|
A:HOH1239
|
4.1
|
19.6
|
1.0
|
HE2
|
A:MET536
|
4.1
|
24.6
|
1.0
|
C31
|
A:XCV1001
|
4.1
|
16.5
|
1.0
|
HB3
|
A:PHE171
|
4.3
|
33.5
|
1.0
|
HE3
|
A:MET536
|
4.3
|
24.6
|
1.0
|
HE1
|
A:MET536
|
4.4
|
24.6
|
1.0
|
CE
|
A:MET536
|
4.4
|
20.5
|
1.0
|
C23
|
A:XCV1001
|
4.6
|
16.2
|
1.0
|
HB3
|
A:LEU187
|
4.6
|
22.3
|
1.0
|
HD21
|
A:LEU191
|
4.7
|
34.8
|
1.0
|
H311
|
A:XCV1001
|
4.7
|
19.8
|
1.0
|
HB2
|
A:PHE171
|
4.7
|
33.5
|
1.0
|
HD13
|
A:LEU187
|
4.8
|
28.0
|
1.0
|
HD1
|
A:TYR168
|
4.8
|
31.4
|
1.0
|
CG
|
A:LEU191
|
4.8
|
22.4
|
1.0
|
C22
|
A:XCV1001
|
4.9
|
17.1
|
1.0
|
CD2
|
A:PHE171
|
4.9
|
40.9
|
1.0
|
CB
|
A:PHE171
|
4.9
|
27.9
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 7l01
Go back to
Fluorine Binding Sites List in 7l01
Fluorine binding site 3 out
of 6 in the Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1001
b:23.4
occ:1.00
|
F29
|
A:XCV1001
|
0.0
|
23.4
|
1.0
|
C26
|
A:XCV1001
|
1.3
|
21.2
|
1.0
|
F27
|
A:XCV1001
|
2.2
|
24.6
|
1.0
|
F28
|
A:XCV1001
|
2.2
|
25.5
|
1.0
|
C25
|
A:XCV1001
|
2.3
|
15.2
|
1.0
|
HB3
|
A:PHE171
|
2.6
|
33.5
|
1.0
|
N30
|
A:XCV1001
|
2.8
|
19.2
|
1.0
|
HG
|
A:CYS175
|
3.3
|
36.6
|
1.0
|
C24
|
A:XCV1001
|
3.4
|
17.9
|
1.0
|
CB
|
A:PHE171
|
3.5
|
27.9
|
1.0
|
SG
|
A:CYS175
|
3.5
|
30.5
|
1.0
|
HB2
|
A:PHE171
|
3.5
|
33.5
|
1.0
|
H241
|
A:XCV1001
|
3.6
|
21.5
|
1.0
|
O
|
A:HOH1239
|
3.8
|
19.6
|
1.0
|
HD2
|
A:PHE171
|
3.9
|
49.1
|
1.0
|
C31
|
A:XCV1001
|
4.1
|
16.5
|
1.0
|
O
|
A:PHE171
|
4.1
|
24.8
|
1.0
|
C
|
A:PHE171
|
4.2
|
26.9
|
1.0
|
HA
|
A:LEU172
|
4.3
|
28.1
|
1.0
|
CG
|
A:PHE171
|
4.4
|
34.5
|
1.0
|
CA
|
A:PHE171
|
4.4
|
24.3
|
1.0
|
CD2
|
A:PHE171
|
4.4
|
40.9
|
1.0
|
C23
|
A:XCV1001
|
4.6
|
16.2
|
1.0
|
N
|
A:LEU172
|
4.6
|
22.6
|
1.0
|
H311
|
A:XCV1001
|
4.6
|
19.8
|
1.0
|
HD13
|
A:LEU187
|
4.7
|
28.0
|
1.0
|
HB2
|
A:CYS175
|
4.8
|
27.5
|
1.0
|
HA
|
A:PHE171
|
4.8
|
29.3
|
1.0
|
C22
|
A:XCV1001
|
4.8
|
17.1
|
1.0
|
CB
|
A:CYS175
|
4.9
|
22.8
|
1.0
|
HD11
|
A:LEU191
|
4.9
|
29.9
|
1.0
|
H
|
A:LEU172
|
4.9
|
27.2
|
1.0
|
CA
|
A:LEU172
|
5.0
|
23.4
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 7l01
Go back to
Fluorine Binding Sites List in 7l01
Fluorine binding site 4 out
of 6 in the Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1001
b:24.4
occ:1.00
|
F27
|
B:XCV1001
|
0.0
|
24.4
|
1.0
|
C26
|
B:XCV1001
|
1.4
|
19.4
|
1.0
|
F28
|
B:XCV1001
|
2.2
|
24.7
|
1.0
|
F29
|
B:XCV1001
|
2.2
|
25.3
|
1.0
|
H241
|
B:XCV1001
|
2.3
|
23.1
|
1.0
|
C25
|
B:XCV1001
|
2.3
|
18.8
|
1.0
|
C24
|
B:XCV1001
|
2.6
|
19.2
|
1.0
|
HD13
|
B:LEU187
|
3.0
|
37.3
|
1.0
|
HB3
|
B:LEU187
|
3.3
|
28.8
|
1.0
|
N30
|
B:XCV1001
|
3.6
|
22.8
|
1.0
|
HD12
|
B:LEU187
|
3.8
|
37.3
|
1.0
|
CD1
|
B:LEU187
|
3.8
|
31.1
|
1.0
|
HB2
|
B:LEU187
|
3.9
|
28.8
|
1.0
|
SG
|
B:CYS175
|
3.9
|
32.0
|
1.0
|
CB
|
B:LEU187
|
4.0
|
23.9
|
1.0
|
HD11
|
B:LEU191
|
4.0
|
29.0
|
1.0
|
C23
|
B:XCV1001
|
4.0
|
17.0
|
1.0
|
HG
|
B:CYS175
|
4.2
|
38.5
|
1.0
|
CG
|
B:LEU187
|
4.5
|
27.6
|
1.0
|
HB3
|
B:PHE171
|
4.5
|
35.8
|
1.0
|
HD11
|
B:LEU187
|
4.6
|
37.3
|
1.0
|
H231
|
B:XCV1001
|
4.6
|
20.5
|
1.0
|
C31
|
B:XCV1001
|
4.6
|
19.9
|
1.0
|
HD12
|
B:LEU191
|
4.7
|
29.0
|
1.0
|
HD22
|
B:LEU187
|
4.8
|
34.9
|
1.0
|
CD1
|
B:LEU191
|
4.8
|
24.1
|
1.0
|
C22
|
B:XCV1001
|
4.9
|
18.4
|
1.0
|
HA
|
B:CYS184
|
5.0
|
25.4
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 7l01
Go back to
Fluorine Binding Sites List in 7l01
Fluorine binding site 5 out
of 6 in the Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1001
b:24.7
occ:1.00
|
F28
|
B:XCV1001
|
0.0
|
24.7
|
1.0
|
C26
|
B:XCV1001
|
1.4
|
19.4
|
1.0
|
F27
|
B:XCV1001
|
2.2
|
24.4
|
1.0
|
F29
|
B:XCV1001
|
2.2
|
25.3
|
1.0
|
C25
|
B:XCV1001
|
2.4
|
18.8
|
1.0
|
HD11
|
B:LEU191
|
2.8
|
29.0
|
1.0
|
N30
|
B:XCV1001
|
2.9
|
22.8
|
1.0
|
C24
|
B:XCV1001
|
3.4
|
19.2
|
1.0
|
CD1
|
B:LEU191
|
3.5
|
24.1
|
1.0
|
H241
|
B:XCV1001
|
3.6
|
23.1
|
1.0
|
HD12
|
B:LEU191
|
3.6
|
29.0
|
1.0
|
HD13
|
B:LEU191
|
3.7
|
29.0
|
1.0
|
HE2
|
B:MET536
|
4.1
|
23.6
|
1.0
|
O
|
B:HOH1219
|
4.1
|
20.2
|
1.0
|
C31
|
B:XCV1001
|
4.1
|
19.9
|
1.0
|
HE3
|
B:MET536
|
4.2
|
23.6
|
1.0
|
HD2
|
B:PHE171
|
4.2
|
45.7
|
1.0
|
HB3
|
B:PHE171
|
4.3
|
35.8
|
1.0
|
HE1
|
B:MET536
|
4.4
|
23.6
|
1.0
|
CE
|
B:MET536
|
4.4
|
19.6
|
1.0
|
C23
|
B:XCV1001
|
4.6
|
17.0
|
1.0
|
HB3
|
B:LEU187
|
4.6
|
28.8
|
1.0
|
HB2
|
B:PHE171
|
4.7
|
35.8
|
1.0
|
H311
|
B:XCV1001
|
4.7
|
23.9
|
1.0
|
HD1
|
B:TYR168
|
4.8
|
28.1
|
1.0
|
HD21
|
B:LEU191
|
4.8
|
38.6
|
1.0
|
C22
|
B:XCV1001
|
4.9
|
18.4
|
1.0
|
CG
|
B:LEU191
|
4.9
|
24.4
|
1.0
|
CB
|
B:PHE171
|
4.9
|
29.7
|
1.0
|
CD2
|
B:PHE171
|
5.0
|
38.0
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 7l01
Go back to
Fluorine Binding Sites List in 7l01
Fluorine binding site 6 out
of 6 in the Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Crystal Structure of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound with Inhibitor DSM782 (N-(1-(5-Cyano-1H-Pyrazol- 3-Yl)Ethyl)-3-Methyl-4-(1-(6-(Trifluoromethyl)Pyridin-3-Yl) Cyclopropyl)-1H-Pyrrole-2-Carboxamide) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1001
b:25.3
occ:1.00
|
F29
|
B:XCV1001
|
0.0
|
25.3
|
1.0
|
C26
|
B:XCV1001
|
1.3
|
19.4
|
1.0
|
F28
|
B:XCV1001
|
2.2
|
24.7
|
1.0
|
F27
|
B:XCV1001
|
2.2
|
24.4
|
1.0
|
C25
|
B:XCV1001
|
2.3
|
18.8
|
1.0
|
HB3
|
B:PHE171
|
2.5
|
35.8
|
1.0
|
N30
|
B:XCV1001
|
2.8
|
22.8
|
1.0
|
HG
|
B:CYS175
|
3.3
|
38.5
|
1.0
|
CB
|
B:PHE171
|
3.3
|
29.7
|
1.0
|
HB2
|
B:PHE171
|
3.3
|
35.8
|
1.0
|
C24
|
B:XCV1001
|
3.5
|
19.2
|
1.0
|
SG
|
B:CYS175
|
3.6
|
32.0
|
1.0
|
H241
|
B:XCV1001
|
3.7
|
23.1
|
1.0
|
O
|
B:HOH1219
|
3.7
|
20.2
|
1.0
|
HD2
|
B:PHE171
|
3.9
|
45.7
|
1.0
|
C31
|
B:XCV1001
|
4.1
|
19.9
|
1.0
|
C
|
B:PHE171
|
4.1
|
26.7
|
1.0
|
CG
|
B:PHE171
|
4.2
|
34.4
|
1.0
|
O
|
B:PHE171
|
4.2
|
25.5
|
1.0
|
CA
|
B:PHE171
|
4.3
|
24.5
|
1.0
|
HA
|
B:LEU172
|
4.4
|
31.0
|
1.0
|
CD2
|
B:PHE171
|
4.4
|
38.0
|
1.0
|
N
|
B:LEU172
|
4.5
|
28.5
|
1.0
|
C23
|
B:XCV1001
|
4.6
|
17.0
|
1.0
|
HA
|
B:PHE171
|
4.7
|
29.0
|
1.0
|
H311
|
B:XCV1001
|
4.7
|
23.9
|
1.0
|
H
|
B:LEU172
|
4.8
|
34.3
|
1.0
|
HB2
|
B:CYS175
|
4.8
|
34.4
|
1.0
|
C22
|
B:XCV1001
|
4.9
|
18.4
|
1.0
|
CA
|
B:LEU172
|
5.0
|
25.8
|
1.0
|
CB
|
B:CYS175
|
5.0
|
28.6
|
1.0
|
|
Reference:
M.Palmer,
X.Deng,
S.Watts,
G.Krilov,
A.Gerasyuto,
S.Kokkonda,
F.Mazouni,
J.White,
K.Schindler,
J.Striepen,
K.White,
D.Shackleford,
J.Bath,
A.Lawong,
A.Huang,
D.Tomchick,
S.Charman,
M.Phillips.
Structure-Guided Optimization of Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series Identifies Compounds with Preclinical Candidate Potential For Treatment of Malaria To Be Published.
Page generated: Fri Aug 2 08:39:13 2024
|